JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M401979200 on March 7, 2004

J. Biol. Chem., Vol. 279, Issue 21, 21824-21832, May 21, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/21/21824    most recent
M401979200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ancsin, J. B.
Right arrow Articles by Kisilevsky, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ancsin, J. B.
Right arrow Articles by Kisilevsky, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

A Binding Site for Highly Sulfated Heparan Sulfate Is Identified in the N Terminus of the Circumsporozoite Protein

SIGNIFICANCE FOR MALARIAL SPOROZOITE ATTACHMENT TO HEPATOCYTES*

John B. Ancsin{ddagger} and Robert Kisilevsky§

From the Department of Pathology and Molecular Medicine, Queen's University and the Syl and Molly Apps Research Center, Kingston General Hospital, Kingston, Ontario Canada, K7L 3N6

Circumsporozoite protein (CSP) coats the malarial sporozoite and functions to target the liver for infection, which is the first step to developing malaria. An important tissue ligand for CSP is the glycosaminoglycan heparan sulfate (HS) found on the surface of hepatocytes and in the basement membrane of the space of Disse. To better understand this efficient targeting process, we set out to identify and characterize the HS binding site(s) of CSP. We synthesized a series of peptides corresponding to five regions of Plasmodium falciparum CSP containing basic residues, a common requirement of HS binding sites, and screened them for heparin and HS binding activity. Only one of these peptides (Pf 2), which contains a motif we have named region I-plus, demonstrated both high affinity heparin/HS binding activity and the ability to block the binding of recombinant CSP to heparin-Sepharose 4B. Analysis by isothermal titration calorimetry revealed that region I-plus has a binding constant of Kd = 5.0 µM and a stoichiometry of n = 7.8 binding sites/heparin chain. Heparin binding was dependent on the amino acid sequence of region I-plus, and the binding sites on heparin/HS are contained within a decasaccharide. Furthermore, HS oligosaccharides rich in sulfate and iduronic acid content (heparin-like) are required for efficient binding. Because liver HS is exceptionally high in both these components relative to the HS of other organs, the HS structural requirements for efficient region I-plus/HS binding are consistent with this peptide sequence functioning to target sporozoites to the liver for attachment to hepatocytes. Finally, the region I-plus heparin/HS binding site was also discovered for two other species that infect humans, Plasmodium malariae and Plasmodium vivax, further supporting the existence of a HS binding domain in the N-terminal portion of CSP.


Received for publication, February 23, 2004 , and in revised form, February 26, 2004.

* This work was supported by a grant from the Bill and Melinda Gates Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Recipient of a Detweiler Traveling Fellowship from the Royal College of Physicians and Surgeons of Canada during the execution of this work.

{ddagger} To whom correspondence should be addressed: Dept. of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario K7L 3N6, Canada. Tel.: 613-548-6048; Fax: 613-533-2907; E-mail: 3jba1{at}post.queensu.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Microbiol. Rev.Home page
J. E. Garcia, A. Puentes, and M. E. Patarroyo
Developmental Biology of Sporozoite-Host Interactions in Plasmodium falciparum Malaria: Implications for Vaccine Design
Clin. Microbiol. Rev., October 1, 2006; 19(4): 686 - 707.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
S. HERRERA, A. BONELO, B. L. PERLAZA, O. L. FERNANDEZ, L. VICTORIA, A. M. LENIS, L. SOTO, H. HURTADO, L. M. ACUNA, J. D. VELEZ, et al.
SAFETY AND ELICITATION OF HUMORAL AND CELLULAR RESPONSES IN COLOMBIAN MALARIA-NAIVE VOLUNTEERS BY A PLASMODIUM VIVAX CIRCUMSPOROZOITE PROTEIN-DERIVED SYNTHETIC VACCINE
Am J Trop Med Hyg, November 1, 2005; 73(5_suppl): 3 - 9.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Trinkaus-Randall, M. T. Walsh, S. Steeves, G. Monis, L. H. Connors, and M. Skinner
Cellular Response of Cardiac Fibroblasts to Amyloidogenic Light Chains
Am. J. Pathol., January 1, 2005; 166(1): 197 - 208.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.